Clinical Trial Update: A Clinical Study of MK-8294 in Participants With Advanced Solid Tumors (MK-8294-001) [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial of MK-8294 in participants with advanced solid tumors is underway, with recruitment currently ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• MK-8294

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Metastatic Neoplasm | Phase 1 | Status: RECRUITING